[1]
E. Crickx, “Clinical Spectrum, Quality of Life, BRAF Mutation Status and Treatment of Skin Involvement in Adult Langerhans Cell Histiocytosis”, Acta Derm Venereol, vol. 97, no. 7, pp. 838–842, May 2017.